Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
103 participants
INTERVENTIONAL
2021-01-06
2021-10-04
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of kcal and PACE Labelling on Self-served Portion Size
NCT04340804
Provision of Small vs. Large Portion Sizes and Later Food Intake
NCT03241576
The Effect of Food Labelling and Satiety on Individuals Food Choice
NCT03537781
Vending Labeling Sales and Intercepts Study
NCT06260176
Facts-Up-Front Versus Traffic-Light Food Labels
NCT01626729
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
PACE plus calorie information intervention group
PACE plus calorie information intervention group will receive PACE plus calorie information of discretionary foods via social media posts.
PACE plus calorie labelling information
The intervention group will be exposed to PACE plus calorie labelling information via Instagram and Twitter social media posts every day for 13 weeks.
Calorie-only information comparator group
Calorie-only information comparator group will receive calorie-only information of discretionary foods via social media posts.
Calorie-only labelling information
The comparator group will be exposed to calorie-only labelling information via Instagram and Twitter social media posts every day for 13 weeks.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
PACE plus calorie labelling information
The intervention group will be exposed to PACE plus calorie labelling information via Instagram and Twitter social media posts every day for 13 weeks.
Calorie-only labelling information
The comparator group will be exposed to calorie-only labelling information via Instagram and Twitter social media posts every day for 13 weeks.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* BMI of ≥ 18.5 kg/m2.
* ≤ 3kg weight loss in previous 6 months.
* Access and ability to use personal Twitter and/or Instagram account via own smartphone, computer or tablet device.
* Access to the internet.
* Access to a set of weighing scales.
Exclusion Criteria
* Experienced in the last 12 months or currently undergoing any of the following conditions or illnesses: coronary heart disease (CHD), hypertension, heart failure, stroke/transient ischaemic attack, atrial fibrillation, type 2 diabetes, chronic obstructive pulmonary disease (COPD), painful condition, dementia and cancer.
* Had bariatric surgery.
* Pregnant, lactating or planning to become pregnant in the next 12 months.
* Parallel participation in another weight, dietary or physical activity intervention study.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Dr Oonagh Markey
UNKNOWN
Alexandra Todd
UNKNOWN
Loughborough University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Amanda Daley
Professor Amanda Daley
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Amanda Daley
Role: PRINCIPAL_INVESTIGATOR
Loughborough University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Loughborough University
Loughborough, Leicestershire, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1544
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.